{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:32:28Z","timestamp":1789687948792,"version":"4.0.1"},"reference-count":47,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anticancer Therapy"],"published-print":{"date-parts":[[2025,4,3]]},"DOI":"10.1080\/14737140.2025.2469755","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T22:51:22Z","timestamp":1740696682000},"page":"327-335","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["An evaluation of vimseltinib for treatment of tenosynovial giant cell tumors"],"prefix":"10.1080","volume":"25","author":[{"given":"Katarzyna","family":"Kisielewska","sequence":"first","affiliation":[{"name":"Maria Sklodowska-Curie National Research Institute of Oncology Warsaw Poland","place":["Warsaw, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Rutkowski","sequence":"additional","affiliation":[{"name":"Maria Sklodowska-Curie National Research Institute of Oncology Warsaw Poland","place":["Warsaw, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1080\/17453674.2017.1361126"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-01883-5"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.2196\/ijmr.9325"},{"key":"e_1_3_4_6_1","first-page":"133","volume-title":"World Health Organization (WHO) classification of soft tissue and bone tumours","author":"De Saint Aubain Somerhausen N","year":"2020","unstructured":"De Saint Aubain Somerhausen N, van de Rijn M. Tenosynovial giant cell tumour. In: CM A, ed. et al. In: World Health Organization (WHO) classification of soft tissue and bone tumours. 5th ed. Lyon: International Agency for Research on Cancer (IARC); 2020. p. 133\u2013136.","edition":"5"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13569-015-0030-2"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102491"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-01820-6"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30100-7"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.otsr.2016.11.002"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2010.07.005"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2024.107953"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26409"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30143-8"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30764-0"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2021-1475"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/onco.13629"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1053\/hupa.2003.52"},{"key":"e_1_3_4_20_1","first-page":"731","article-title":"Pigmented villonodular synovitis, bursitis and tenosynovitis","volume":"31","author":"Jaffe HL","year":"1941","unstructured":"Jaffe HL, Lichtenstein L, Sutro CJ. Pigmented villonodular synovitis, bursitis and tenosynovitis. Arch Pathol. 1941;31:731\u2013765.","journal-title":"Arch Pathol"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0507321103"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20501"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32421"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.22807"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a021857"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21641"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2022.2067040"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-1898"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy129"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12010100"},{"key":"e_1_3_4_31_1","unstructured":"Created in BioRender. Available from: https:\/\/BioRender.com\/o94z717"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2022.128928"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-21-0361"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2022.128928"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-24-0103"},{"key":"e_1_3_4_36_1","volume-title":"Presented at: European Society for Medical Oncology (ESMO) Congress","author":"Blay JY","year":"2022","unstructured":"Blay JY, Gelderblom H, Rutkowski P et al, Efficacy and safety of vimseltinib in tenosynovial giant cell tumor (TGCT): phase 2 expansion. In: Presented at: European Society for Medical Oncology (ESMO) Congress. Paris, France; 2022 European Society for Medical Oncology (ESMO) Sep 9\u201313."},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2023-0238"},{"key":"e_1_3_4_38_1","volume-title":"Presented at: American Society of Clinical Oncology (ASCO) Annual Meeting 2024","author":"Tap WD","unstructured":"Tap WD, Bhadri V, Stacchiotti S, et al. Efficacy, safety, and patient-reported outcomes of vimseltinib in patients with tenosynovial giant cell tumor: results from the phase 3 MOTION trial Oral Abstract Session 11500. In: Presented at: American Society of Clinical Oncology (ASCO) Annual Meeting 2024; 31 May-4 June; Chicago, (IL), USA."},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.08.275"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2011.03.029"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2011.29.15_suppl.3093"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.35.15_suppl.11078"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.09.038"},{"key":"e_1_3_4_44_1","unstructured":"NCCN Guidelines. [cited 2024 Nov 1]. Available from: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1464"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/jso.27410"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S253232"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01210-0"},{"key":"e_1_3_4_48_1","volume-title":"ISOLS\/MSTS Annual Meeting","author":"Cheng E","year":"2015","unstructured":"Cheng E, Kudlidjian A, Block J, et al. MCS110, an anti\u2010csf\u20101 antibody, for the treatment of pigmented villonodular synovitis (PVNS). In: ISOLS\/MSTS Annual Meeting; Orlando, (FL), USA; 2015 Oct 6\u201310."},{"key":"e_1_3_4_49_1","unstructured":"EU approval sought for vimseltinib in tenosynovial giant cell tumor. [cited 2024 Nov 1]. Available from: https:\/\/www.onclive.com\/view\/eu-approval-sought-for-vimseltinib-in-tenosynovial-giant-cell-tumor"}],"container-title":["Expert Review of Anticancer Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737140.2025.2469755","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T09:47:44Z","timestamp":1743500864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737140.2025.2469755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4,3]]}},"alternative-id":["10.1080\/14737140.2025.2469755"],"URL":"https:\/\/doi.org\/10.1080\/14737140.2025.2469755","relation":{},"ISSN":["1473-7140","1744-8328"],"issn-type":[{"value":"1473-7140","type":"print"},{"value":"1744-8328","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-11-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}